FDA oversight Archives - Pharma Marketing Network

Home Tags FDA oversight

Patient comparing branded, generic, and compounded medications in a modern pharmaceutical setting representing healthcare decision-making and FDA oversight.

Compounded vs. Branded vs. Generic: The New Battle for Patient Understanding

Donna Pacheco - May 11, 2026

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Patient comparing branded, generic, and compounded medications in a modern pharmaceutical setting representing healthcare decision-making and FDA oversight.

Compounded vs. Branded vs. Generic: The New Battle for Patient Understanding

May 11, 2026

Digital healthcare ecosystem showing telehealth, online pharmacy services, and connected patient experiences across modern healthcare platforms.

The Platform Problem: When Telehealth and Retail Own the Pharma Customer...

May 11, 2026

Pharmaceutical compliance office showing MLR review documents, regulatory communications, and digital compliance monitoring tools

Press Releases Are Now Promotional: Why Pharma Comms Needs an MLR...

May 8, 2026